drugset / Trial / NCT06792344
Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis
Phase 1
Recruiting
12 enrolled
The Children's Hospital of Zhejiang University School of Medicine
Guangzhou Women and Children's Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of childhood-onset systemic sclerosis
Timeline
- Start
- 2024-12-15
- Primary completion
- 2027-12-30
- Completion
- 2027-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | anti-CD19 CAR-T cells | Cell therapy | — | Intravenous |